C-peptide: difference between revisions
Diff·revision 18 → 19·14:42, 27 Jul 2025
Difference between revision 18 and revision 19 of C-peptide. 2 lines changed; the page grew by 167 bytes.
| Revision 18 — 01:04, 26 Jun 2025 CRP_Cormac (talk) add the sample-stability sentence with its storage condition 4,233 bytes ±0 | Revision 19 — 14:42, 27 Jul 2025 HOMA_Hettie (talk) state which fraction the assay actually measures 4,400 bytes +167 | ||
|---|---|---|---|
| 38 | Improvements in C-peptide-derived indices during treatment are frequently reported and are frequently over-interpreted: an improved index under continuing treatment is not evidence of a durable change in the beta cell. See [[Beta cell function]].{{r|jones2013}} | 38 | Improvements in C-peptide-derived indices during treatment are frequently reported and are frequently over-interpreted: an improved index under continuing treatment is not evidence of a durable change in the beta cell. See [[Beta cell function]].{{r|jones2013}} |
| 39 | 39 | ||
| + | 40 | C-peptide appears on some baseline laboratory panels discussed in this field; see [[Baseline laboratory panel]]. Nothing on this wiki is medical advice.{{r|ada2024}} | |
| + | 41 | ||
| 40 | == References == | 42 | == References == |
| 41 | {{reflist}} | 43 | {{reflist}} |